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HE Rh BLOOD GROUP SYSTEM is of clinical interest
because Rh antibodies are involved in the immunemediated destruction of red blood cells (RBCs), eg, after transfusion with Rh incompatible blood or in hemolytic disease of the newborn (HDN).' Most commonly, HDN is caused by maternal antibodies directed against the Rh D antigen, despite common useage of Rh immune globulin prophylaxis. The maternal antibodies are formed in response to alloimmunization of the mother by fetal RBCs after delivery or sometimes late in the first pregnancy, if there is fetalmaternal incompatibility. In subsequent pregnancies, it is important to investigate the Rh D status of the fetus, especially when the father is heterozygous for the Rh D antigen. Prenatal determination of the fetal Rh D genotype will thus help in the antenatal management of fetuses at risk. Unnecessary invasive diagnostic methods and expensive therapeutic strategies will be prevented in case the fetus is D negative.
Recently, it has been established that the Rh locus on chromosome 1 p34.3-p36.1 comprises at least two distinct, but highly homologous genes, a D gene and a CcEe gene. 2 
,'
The Rh D-negative phenotype is caused by a deletion of the Rh D gene rather than by an allele of this gene. Complementary DNA derived from the Rh D gene, encoding the Rh D polypeptide, has been characterized?"j It has been proposed that full-length messenger RNA transcript derived from the Rh CcEe gene encodes the polypeptide carrying the Ele antigens, whereas, by alternative splicing, shorter polypeptides are produced that carry the Clc antigens.'.' Several characteristic nucleotide differences between the Rh D cDNA and the non-D cDNAs have been ob~erved.~.~.~" ' Colin et a13 were the first to report the applicability of Southern blotting of genomic DNA to determine the Rh D genotype. However, because this assay is time-consuming and requires a relatively large number of cells, its usefulness in the routine laboratory, especially in prenatal testing, is limited. Recently, Bennett et all2 were able to determine the Rh D genotype of 15 fetuses using DNA derived from amniocytes in the polymerase chain reaction (PCR). This genotyping with the second method was performed by PCR amplification of exon 7 of the D gene with allele-specific primers. In all donors phenotyped as D positive tested so far (n = 1781, the results of molecular genotypihg with this method were concordant with the serololgic results, whereas a false-positive result was obtained in one of the D-negative donors (also false-positive in the first method). Complete agreement was found between genotypes determined in the third method, based on a 600-bp deletion in intron 4 of the Rh D gene described by Arce ut al (Blood 82:651,1993), and serologically determined phehotypes. The Rh blood group system is complex, and unknown polymorphisms at the DNA level are expected to exist. Therefore, although genotypes determined by the method of Arce et al were in agreement with serotypes, it cannot yet be regarded as the golden standard. More experience with this or other methods is still needed. assay is more suitable for routine application. However, we have encountered discrepancies between the results of serologic typing and of genotyping by this assay.13 This was not an unexpected finding, because this assay is based on sequence differences between the D and CcEe genes in the 3' noncoding regions. This finding prompted us to evaluate the reliability of three different PCR-based Rh D typing methods. Genomic DNA derived from 234 individuals with a known Rh D phenotype were used for this purpose.
MATERIALS AND METHODS

Serology
Rh D phenotyping of the individuals under investigation was performed with standard methods using polyclonal as well as monoclonal antibodies, as described. ' 
DNA Preparation
The mononuclear cell fraction was isolated by density gradient centrifugation and used to prepare DNA according to the method described by Ciulla et al.14 specific nucleotides in oligonucleotide primers A7 and A8 are underlined. In primers A10 and A l l , the small written nucleotides are not part of the coding sequence, but are added as a restriction site that can be used for cloning purposes. These nucleotides are not involved in the numbering of the primer nucleotides.
PCR Ampl(jiccuior1
The PCR was performed i n a Perkin-Elmer Cetus Thermal Cycler Table 1 for the sequences) were purchased from Applied Biosystems (Palo Alto. CA). The primers AX and A9 were purified with oligonucleotide purification cartridges (Applied Biosystems, Foster City. CA).
PCR Strrrtegies I. II. and III
Mcthod 1.
Method I was performed as described" (see Table I for the oligonucleotide primer sequences A I . A2, A3, and A4). Method 11. The first primer set AS and A6 (see Table I for the sequences) i s used as consensus primers to amplify a 141-bp segment from exon S o f both the Rh D and the Rh Cc& gene. I n contrast, primers A7 and A8 are specific for exon 7 o f the Rh D gene only. Thus, with these allele-specific primers (ASPA). a 96-bp product will only be obtained with DNA from Rh D-positive subjects (for a schematic representation. see Fig 2A) . Analysis of the PCR products was performed by electrophoresis in an 8%-polyacrylamide gel and subsequent ethidium bromide staining and UV illumination was used to visualize the amplimers. 95°C of denaturation. I .5 minutes at S S T of primer annealing, and 2.5 minutes at 72°C of extension, followed by a final cycle of 9 minutes at 72°C.
Note that in all three PCR typing methods an internal control was included to check the efficiency of the Taq DNA polymerase used.
In methods I and 11, a second primer set that yields a PCR product regardless of the Rh D genotype was used. In method Ill. only one primer set was applied. This primer set is sufficient for both checking the efficiency of the PCR and for typing for the Rh D gene. for the reasons stated above. 
Southern Blot Analwis
Southern blot analysis was performed according to standard methods. ' Genomic DNA was digested with the restriction endonuclease Table I for the sequences). Genomic DNA from the discrepant cases was used for this purpose. The PCR products were digested with Dde I according to conditions 2% agarose For personal use only. on September 24, 2017. by guest www.bloodjournal.org From 
RESULTS
Rh D Genotyping Using Method I and the Correlation of the Results With Those of Serotyping
We determined the Rh D phenotypes of 234 individuals. Of these 234 individuals, 178 were typed as Rh D positive and 56 as Rh D negative ( Table 2 ). Figure 1B shows a representative example of the characteristic bands visualized on polyacrylamide gels. The samples containing only the 136-bp band were scored as Rh D negative (lanes 4 and 5), whereas those containing in addition the band of 186 bp were scored as Rh D positive (lanes 1 through 3) . The genotypes of the individuals studied with method I are summarized in Table 2 . Two of the 178 subjects phenotyped as Rh D positive (father and child) were genotyped as D negative. Three of the 56 subjects phenotyped as Rh D negative were genotyped as D positive.
Rh D Genotyping Using Method II and the Correlation of the Results With Those c$ Serotyping
As can be seen in Table 1 , primer A7 as well as primer A8 contain 6 Rh D-specific nucleotides. Most importantly, the 3' end of both primers contains Rh D-specific nucieotides. As expected, the Rh D-negative samples contained only the control PCR product, with a size of 141 bp ( Fig  2B, lanes I , 4, and 5) , whereas the Rh D-positive samples contained also a Rh D-specific PCR product with a size of 96 bp in addition ( Fig 2B, lanes 2, 3, and 6 ). However, one Rh D-negative individual was typed in this PCR assay as Rh D positive (Table 2 ). This false-positive case was also observed in method I.
Rh D Genotyping Using Method III and the Correlation of These Results With Those of Serotyping
As can be seen in Fig 3B, 5) . In all individuals studied so far, no discrepancies between serotyping and DNA typing (method 111) were encountered ( Table 2) .
Discrepant Cases
PCR-ASRA.
The discrepancies between serology and the DNA assays are summarized in Table 3 . PCR-ASRA (Dde I ) with the discrepant cases was performed to evaluate whether the C'"' + A and G5"" "-t T nucleotide mutations in the more upstream located exon 4 are normally present in these Rh D-positive individuals. This study showed the presence of the expected fragments with a size of 67 bp and 27 bp (data not shown) in Rh D-negative individuals (indicated with a minus in Table 3 ) and fragments of 94 bp. 67 bp, and 27 bp (data not shown) in Rh D-positive individuals (indicated with a plus in Table 3 ) .
Southern blot unulysis.
To further evaluate the discrepant results, genomic DNA from the discrepant cases no. 1. 2, 3, and 5 were digested with BnrnHI restriction enzyme and subjected to Southern blot analysis with the full-length Rh cDNA probe (Fig 4) . Unfortunately, for case no. 4 there was not enough DNA available to perform Southern blot analysis and we could not obtain any more material. DNAs from D-negative (dccee, lane I ; dCcee, lane 3) and D-positive (DCcee, lane 5 ) donors were used as control.
For cases no. I and 2 (father and child), the Southern blot showed exactly the same pattern as for normal Rh D-positive donors (results not shown).
For cases no. 3 and 5 , the results from the Southern blot analysis are shown in Fig 4, lanes 4 and 2, respectively. In case no. 3, the D-specific band of 16 kb, corresponding to the 3' region of the D gene,3 was present. However, the 4.0-kb D-specific band (exons 4, 5 , and 6") was missing, whereas an additional fragment of approximately 4.6 kb appeared. In agreement with the PCR results of methods 1 and 111, in case no. 5 the D-specific 16-kb band was present, whereas the 4.0-kb D-specific band was missing; however, an additional band of approximately 12 kb was seen.
DISCUSSION
We have compared three different Rh D genotyping methods using genomic DNA from 234 donors. The results of only one of the three methods studied (method 111) were in full agreement with those of serotyping in individuals with a normal Rh D phenotype.
DNA typing for Rh D in method I is based on the difference in the 3' noncoding regions of the Rh D and the Rh CcEe gene. Also, in method 111 a difference in a noncoding region, ie, an intronic sequence (flanked by exons 4 and 5 ) of the Rh D-and the Rh CcEe gene, is used to differentiate Rh D-positive from Rh D-negative individuals. In our opinion, more reliable distinction for Rh D positivity and Rh D negativity at the molecular level would be expected based on differences in the coding regions. Therefore, we took advantage of the major nucleotide differences in exon 7 of the Rh D and Rh CcEe genes. Based on this knowledge, the primers A7 and A8 were constructed and used in the ASPA for the determination of Rh D genotypes. The discrepant case no. 3 (Table 3) , which was already encountered in assay I, remained false positive in this assay.
From the results of the PCR-based methods using DNA from cases no. 1 and 2 (a father and child, who were both typed D negative in method I and D positive in methods I1 and Ill and serology), we may conclude that the 3' noncoding region of the Rh D gene in these two individuals is altered or deleted. However, the patterns in Southern blot analysis were not different from patterns obtained with DNA from a normal Rh D-positive donor. From these results we can conclude that there is no deletion in the D gene in these individuals, but that probably the 3' region of the D gene is altered so that primer A3 or A4 can no longer anneal. The false-positivity in cases no. 4 and 5 may be caused by a partial deletion of the Rh D gene in the concerning region, ie, the Rh D gene in these individuals is not entirely deleted, but still contains its 3' region. Unfortunately, for case no. 4 there was not enough material to perform a Southern blot 2979 analysis. Indeed. Southern blot analysis of case no. S showed the presence of the 16-kb band corresponding to the 3' noncoding region of the D gene. whereas the 4.0-kb band was missing. Rut, in addition. an extra restriction fragment of approximately 12 kb was found. Because we were not able to obtain enough material from thc parents. we could not confirm the origin of this band.
It could be that the 16-kb band was inherited from onc parent and that the 12-kb band was inherited from the other parent. This would mean that both parents have an abnormal Rh D gene. In case no. 3. the subject was typed D negative by both serology and two DNA-methods (methods 111 and IV [exon 4 ASRA]). but D positive by two other DNA methods (methods I and 11). Southern blot analysis showed an abnormal bancl of 4.6 kb. whereas the band of 4.0 kb present in case of D positivity was missing. An identical restriction fragment lcnpth pattern had been found earlier by Mouro et all5 when they described the rearrangements involved in the Rh DV' variant (see below). Thus, in this case we are probably dealing with the Rh DV' type, which was not noticed in serology.
Mouro The concordance of the results in method Ill and the ASRA with Dde I in exon 4 (only performed in the discrepant cases) with those of serology and the discordance of the results in method I and method I1 in some cases all together suggest that the major Rh D epitopes are located upstream from exon 7.
Our main aim was to construct a reliable molecular genotyping technique for Rh D for prenatal typing fetuses at risk. Accurate prediction of the Rh genotypes of fetuses is crucial when the risks and costs of prenatal interventions, including fetal blood sampling and high-dose intravenous Ig administration to the mother, are considered. Until recently. prenatal determination of the fetal Rh D status could only be performed by fetal blood sampling. Southern blot analysis of genomic DNA for the determination of the Rh D genotypes is an impractical technique. 3 In contrast to the simplicity of the molecular basis of the platelet all~antigens,'~''" there are many differences within the coding as well as in the noncoding regions of the Rh D-and Rh CcEe genes. Moreover, it is likely that these differences will vary among individuals. The Rh gene frequencies as well as the frequencies of the different Rh haplotypes vary among individuals from different racial backgrounds. Therefore, it is also likely that there will be differences in the Rh D genes. Although we and others have For personal use only. on September 24, 2017. by guest www.bloodjournal.org From shown that nucleotide differences that result in amino acid substitutions between the Rh D gene and the non-D gene are indeed linked to the Rhesus phenotype,'." more investigations are needed to correlate the Rh genes and the Rh phenotypes because the association between the characteristic amino acids of the Rh D polypeptide and their immunogenicity still remains to be determined.
In conclusion, the three different approaches presented in this report to genotype for Rh D were useful but not sufficient in all cases. Additional methods, such as PCR-ASRA, as well as simultaneous analysis of parental DNA, may prove necessary, especially in case RBCs are not available for phenotyping. For some cases, a possible discrepancy between the results of serotyping and genotyping in the parents can be detected in this way, thus decreasing the risk of a false-negative result for the fetus. More research is necessary to understand the nature of these discrepancies.
